On the inflammatory response in metal-on-metal implants

Journal of Translational Medicine

Gertrud Maria Hänsch¹  Volker Ewerbeck³  Jan Philippe Kretzer³  Burkhard Lehner³  Jörn Reinders³  Felix Lasitschka²  Thomas Giese¹  Ulrike Dapunt³ 

[1] Department of Immunology, Heidelberg University, Im Neuenheimer Feld 305, 69120 Heidelberg, Germany;Department of Pathology, Heidelberg University, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany;Department of Orthopaedics and Trauma Surgery, University Hospital Heidelberg, Schlierbacher Landstrasse 200a, 69118 Heidelberg, Germany

关键词: Osteolysis;    Cytokines;    T-cell response;    Innate immune response;    Metal wear particles;    Metal-on-metal implants;   

Others  :  817593
DOI  :  10.1186/1479-5876-12-74

 received in 2014-01-21, accepted in 2014-03-10,  发布年份 2014

【 摘 要 】

Background

Metal-on-metal implants are a special form of hip endoprostheses that despite many advantages can entail serious complications due to release of wear particles from the implanted material. Metal wear particles presumably activate local host defence mechanisms, which causes a persistent inflammatory response with destruction of bone followed by a loosening of the implant. To better characterize this inflammatory response and to link inflammation to bone degradation, the local generation of proinflammatory and osteoclast-inducing cytokines was analysed, as was systemic T cell activation.

Methods

By quantitative RT-PCR, gene expression of cytokines and markers for T lymphocytes, monocytes/macrophages and osteoclasts, respectively, was analysed in tissue samples obtained intraoperatively during exchange surgery of the loosened implant. Peripheral T cells were characterized by cytofluorometry before surgery and 7 to 10 days thereafter.

Results

At sites of osteolysis, gene expression of cathepsin K, CD14 and CD3 was seen, indicating the generation of osteoclasts, and the presence of monocytes and of T cells, respectively. Also cytokines were highly expressed, including CXCL8, IL-1ß, CXCL2, MRP-14 and CXCL-10. The latter suggest T cell activation, a notion that could be confirmed by detecting a small, though conspicuous population of activated CD4+ cells in the peripheral blood T cells prior to surgery.

Conclusion

Our data support the concept that metallosis is the result of a local inflammatory response, which according to histomorphology and the composition of the cellular infiltrate classifies as an acute phase of a chronic inflammatory disease. The proinflammatory environment, particularly the generation of the osteoclast-inducing cytokines CXCL8 and IL1-ß, promotes bone resorption. Loss of bone results in implant loosening, which then causes the major symptoms of metallosis, pain and reduced range of motion.

【 授权许可】

   
2014 Dapunt et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Learmonth ID, Young C, Rorabeck C: The operation of the century: total hip replacement. Lancet 2007, 370(9597):1508-1519.
• [2]Goodman SB: Wear particles, periprosthetic osteolysis and the immune system. Biomaterials 2007, 28(34):5044-5048.
• [3]Shimmin A, Beaule PE, Campbell P: Metal-on-metal hip resurfacing arthroplasty. J Bone Joint Surg Am 2008, 90(3):637-654.
• [4]Grigoris P, Roberts P, Panousis K, Jin Z: Hip resurfacing arthroplasty: the evolution of contemporary designs. Proc Inst Mech Eng H 2006, 220(2):95-105.
• [5]Ollivere B, Darrah C, Barker T, Nolan J, Porteous MJ: Early clinical failure of the Birmingham metal-on-metal hip resurfacing is associated with metallosis and soft-tissue necrosis. J Bone Joint Surg (Br) 2009, 91(8):1025-1030.
• [6]de Steiger RN, Hang JR, Miller LN, Graves SE, Davidson DC: Five-year results of the ASR XL acetabular system and the ASR hip resurfacing system: an analysis from the Australian Orthopaedic Association National Joint Replacement Registry. J Bone Joint Surg Am 2011, 93(24):2287-2293.
• [7]Steele GD, Fehring TK, Odum SM, Dennos AC, Nadaud MC: Early failure of articular surface replacement XL total hip arthroplasty. J Arthroplasty 2011, 26(6 Suppl):14-18.
• [8]Langton DJ, Jameson SS, Joyce TJ, Hallab NJ, Natu S, Nargol AV: Early failure of metal-on-metal bearings in hip resurfacing and large-diameter total hip replacement: a consequence of excess wear. J Bone Joint Surg (Br) 2010, 92(1):38-46.
• [9]Cuckler JM: Metal-on-metal surface replacement: a triumph of hope over reason: affirms. Orthopedics 2011, 34(9):e439-e441.
• [10]MacDonald SJ: Metal-on-metal total hip arthroplasty: the concerns. Clin Orthop Relat Res 2004, 429:86-93.
• [11]Park YS, Moon YW, Lim SJ, Yang JM, Ahn G, Choi YL: Early osteolysis following second-generation metal-on-metal hip replacement. J Bone Joint Surg Am 2005, 87(7):1515-1521.
• [12]Haddad FS, Thakrar RR, Hart AJ, Skinner JA, Nargol AV, Nolan JF, Gill HS, Murray DW, Blom AW, Case CP: Metal-on-metal bearings: the evidence so far. J Bone Joint Surg (Br) 2011, 93(5):572-579.
• [13]Benson MK, Goodwin PG, Brostoff J: Metal sensitivity in patients with joint replacement arthroplasties. Br Med J 1975, 4(5993):374-375.
• [14]Pazzaglia UE, Ceciliani L, Wilkinson MJ, Dell'Orbo C: Involvement of metal particles in loosening of metal-plastic total hip prostheses. Arch Orthop Trauma Surg 1985, 104(3):164-174.
• [15]Willert HG, Semlitsch M: Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res 1977, 11(2):157-164.
• [16]Hallab N, Merritt K, Jacobs JJ: Metal sensitivity in patients with orthopaedic implants. J Bone Joint Sur 2001, 83(3):428.
• [17]Willert HG, Buchhorn GH, Fayyazi A, Flury R, Windler M, Koster G, Lohmann CH: Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints, a clinical and histomorphological study. J Bone Joint Surg Am 2005, 87(1):28-36.
• [18]Huber M, Reinisch G, Trettenhahn G, Zweymuller K, Lintner F: Presence of corrosion products and hypersensitivity-associated reactions in periprosthetic tissue after aseptic loosening of total hip replacements with metal bearing surfaces. Acta Biomater 2009, 5(1):172-180.
• [19]Davies AP, Willert HG, Campbell PA, Learmonth ID, Case CP: An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Joint Surg Am 2005, 87(1):18-27.
• [20]Natu S, Sidaginamale RP, Gandhi J, Langton DJ, Nargol AV: Adverse reactions to metal debris: histopathological features of periprosthetic soft tissue reactions seen in association with failed metal on metal hip arthroplasties. J Clin Pathol 2012, 65(5):409-418.
• [21]Campbell P, Ebramzadeh E, Nelson S, Takamura K, De Smet K, Amstutz HC: Histological features of pseudotumor-like tissues from metal-on-metal hips. Clin Orthop Relat Res 2010, 468(9):2321-2327.
• [22]Ingham E, Fisher J: The role of macrophages in osteolysis of total joint replacement. Biomaterials 2005, 26(11):1271-1286.
• [23]Hallab N: Metal sensitivity in patients with orthopedic implants. J Clin Rheumatol 2001, 7(4):215-218.
• [24]Kwon YM, Thomas P, Summer B, Pandit H, Taylor A, Beard D, Murray DW, Gill HS: Lymphocyte proliferation responses in patients with pseudotumors following metal-on-metal hip resurfacing arthroplasty. J Orthop Res 2010, 28(4):444-450.
• [25]Baldwin L, Flanagan BF, McLaughlin PJ, Parkinson RW, Hunt JA, Williams DF: A study of tissue interface membranes from revision accord knee arthroplasty: the role of T lymphocytes. Biomaterials 2002, 23(14):3007-3014.
• [26]Kotsougiani D, Pioch M, Prior B, Heppert V, Hansch GM, Wagner C: Activation of T lymphocytes in response to persistent bacterial infection: induction of CD11b and of toll-like receptors on T Cells. Int J Inflamm 2010, 2010:526740.
• [27]Gaida MM, Mayer B, Stegmaier S, Schirmacher P, Wagner C, Hänsch GM: Polymorphonuclear neutrophils in osteomyelitis: link to osteoclast generation and bone resorption. European J of Inflammation 2012, 10:413-426.
• [28]Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD: Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res 1989, 4(1):113-118.
• [29]Ha J, Lee Y, Kim HH: CXCL2 mediates lipopolysaccharide-induced osteoclastogenesis in RANKL-primed precursors. Cytokine 2011, 55(1):48-55.
• [30]Henderson B, Nair SP: Hard labour: bacterial infection of the skeleton. Trends Microbiol 2003, 11(12):570-577.
• [31]Mandelin J, Li TF, Liljestrom M, Kroon ME, Hanemaaijer R, Santavirta S, Konttinen YT: Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg (Br) 2003, 85(8):1196-1201.
• [32]Wada T, Nakashima T, Hiroshi N, Penninger JM: RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006, 12(1):17-25.
• [33]Wagner C, Kondella K, Bernschneider T, Heppert V, Wentzensen A, Hansch GM: Post-traumatic osteomyelitis: analysis of inflammatory cells recruited into the site of infection. Shock 2003, 20(6):503-510.
• [34]Gesser B, Lund M, Lohse N, Vestergaad C, Matsushima K, Sindet-Pedersen S, Jensen SL, Thestrup-Pedersen K, Larsen CG: IL-8 induces T cell chemotaxis, suppresses IL-4, and up-regulates IL-8 production by CD4+ T cells. J Leukoc Biol 1996, 59(3):407-411.
• [35]Taub DD, Lloyd AR, Wang JM, Oppenheim JJ, Kelvin DJ: The effects of human recombinant MIP-1 alpha, MIP-1 beta, and RANTES on the chemotaxis and adhesion of T cell subsets. Adv Exp Med Biol 1993, 351:139-146.
• [36]Qin S, LaRosa G, Campbell JJ, Smith-Heath H, Kassam N, Shi X, Zeng L, Buthcher EC, Mackay CR: Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur J Immunol 1996, 26(3):640-647.
• [37]Sallusto F, Geginat J, Lanzavecchia A: Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004, 22:745-763.
• [38]Innocenti M, Carulli C, Matassi F, Carossino AM, Brandi ML, Civinini R: Total knee arthroplasty in patients with hypersensitivity to metals. Int Orthop 2014, 38(2):329-333.
• [39]Hart AJ, Hester T, Sinclair K, Powell JJ, Goodship AE, Pele L, Fersht NL, Skinner J: The association between metal ions from hip resurfacing and reduced T-cell counts. J Bone Joint Surg (Br) 2006, 88(4):449-454.
• [40]Wagner M, Klein CL, van Kooten TG, Kirkpatrick CJ: Mechanisms of cell activation by heavy metal ions. J Biomed Mater Res 1998, 42(3):443-452.